Evidence map›Paper›PMID 38140166›Full record

ArticleVaccines2023

Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis.

Giulia Del Duca, Alessandro Tavelli, Ilaria Mastrorosa, Camilla Aguglia, Simone Lanini, Anna Clelia Brita, Roberta Gagliardini, Serena Vita, Alessandra Vergori, Jessica Paulicelli and 22 more

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Observational
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 7 institutions in 1 country.

Giulia Del DucaClinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.ORCID 0009-0004-3408-3817
Alessandro TavelliIcona Foundation, 20142 Milan, Italy.ORCID 0000-0001-5899-451X
Ilaria MastrorosaClinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.ORCID 0000-0003-1944-662X
Camilla AgugliaClinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
Simone LaniniClinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.ORCID 0000-0002-6743-4001
Anna Clelia BritaClinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
Roberta GagliardiniClinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.ORCID 0000-0002-6351-2623
Serena VitaClinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
Alessandra VergoriClinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.ORCID 0000-0001-6944-0686
Jessica PaulicelliClinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
Giorgia NataliniClinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
Angela D'UrsoClinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
Pierluca PiselliDepartment of Epidemiology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.ORCID 0000-0002-7342-0263
Paola GallìHealth Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
Vanessa MondilloHealth Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
Claudio MastroianniDepartment of Public Health and Infectious Diseases, Sapienza University, AOU Policlinico Umberto 1, 00161 Rome, Italy.ORCID 0000-0002-1286-467X
Enrica TamburriniFondazione Policlinico A. Gemelli, Catholic University of the Sacred Heart, 00168 Rome, Italy.
Loredana SarmatiDepartment of System Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0003-1452-0333
Christof StingoneSTI/HIV Unit, San Gallicano IRCCS Dermatological Institute, 00144 Rome, Italy.
Miriam LichtnerNeuroscience Mental Health and Sense Organs Department, Sapienza University of Rome, Polo Pontino, 04100 Latina, Italy.ORCID 0000-0002-7730-3953
Emanuele NicastriClinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.ORCID 0000-0002-5606-8712
Massimo FarinellaCircolo di Cultura Omosessuale Mario Mieli, 00146 Rome, Italy.
Filippo LeserriPlus Roma, 00182 Rome, Italy.
Andrea SidduGeneral Directorate of Prevention, Ministry of Health, 00197 Rome, Italy.
Fabrizio MaggiLaboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.ORCID 0000-0001-7489-5271
Antonella d'Arminio MonforteIcona Foundation, 20142 Milan, Italy.ORCID 0000-0003-0073-1789
Francesco VairoDepartment of Epidemiology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
Alessandra BarcaUnit of Health Promotion and Prevention, Directorate of Health and Integration, Lazio Region, 00145 Rome, Italy.
Francesco VaiaGeneral Directorate of Prevention, Ministry of Health, 00197 Rome, Italy.
Enrico GirardiScientific Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.ORCID 0000-0001-8182-5896
Valentina MazzottaClinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.ORCID 0000-0002-0240-7504
Andrea AntinoriClinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.ORCID 0000-0003-2121-4684
Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · ITMinistero della Salute · ITUniversity of Rome Tor Vergata · ITPoliclinico Umberto I · ITSan Gallicano Hospital · ITSapienza University of Rome · ITUniversità Cattolica del Sacro Cuore · IT

Funding

Italian Ministry of Health (Ricerca Corrente Linea 2) NANational Institute for Infectious Diseases "Lazzaro Spallanzani" in Rome, Italy (project 5x1000) 2021 NA
6 · The paper itself

Abstract

backgroundwe aim to investigate attitudes toward vaccination by analyzing empirical factors associated with vaccine acceptance in the Lazio region mpox vaccination (MpoxVax) campaign in Italy.

methodsall subjects who accessed MpoxVax and signed the informed consent were prospectively enrolled in the MPOX-VAC Study and were asked to fill out an anonymous survey. Two endpoints were selected: 'delayed acceptance' and 'early acceptance', defined as access for vaccination >60 and ≤30 days from the vaccination campaign starting (VCS), respectively.

resultsover the study period, 1717 individuals underwent vaccination: 129 (7%) > 60 [1588 (92.5%) ≤ 60] and 676 (60%) ≤ 30 days from VCS. A bisexual orientation, a lower education level and a worse perceived physical and mental health were associated with delayed access to vaccination. Being pre-exposure prophylaxis (PrEP) users and, marginally, HIV positive; having a high perceived risk for mpox infection; and reporting high-risk behaviors like the use of recreational drugs/chems, sex under the influence of drugs and/or alcohol and having a higher number of principal sexual partners, were associated with early access to vaccination.

conclusionsaccording to our data, risk awareness was a major determinant of early MpoxVax acceptance. Conversely, worse perceived health status and a low educational level were critical factors associated with delayed vaccination.

Indexed as

health-related quality of lifempox infectionmpox vaccinationrisk awarenessthe short-form 36-item questionnairevaccine acceptancevaccine hesitancy

Identifiers

PMID38140166
PMCPMC10748194
OpenAlexW4389050488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.